non-IDU / HCV / Thomson / Hepatitis C Virus Projections Working Group / IDU / /
Country
United States / Canada / Australia / /
Currency
USD / / /
Event
FDA Phase / M&A / /
Facility
Burnet Institute / /
IndustryTerm
treatment of hepatitis C / Hepatitis C Therapy / comparison / treatment treatment protocol / outpatient services / infectious diseases Treatment / treatment protocols / care for hepatitis C / treatment for hepatitis C / treatment protocol / Hepatitis C Treatment / /
MedicalCondition
acute viral hepatitis / concomitant alcohol abuse / former heroin users / hepatitis C / recently acquired hepatitis C / drug dependence / former heroin user / Hepatitis / acute hepatitis C. This / hepatitis C. In / successful hepatitis C / infections / alcoholism / acute hepatitis C / Viral cancers / both chronic and acute hepatitis / chronic infections / liver fibrosis / Clinical Infectious Diseases / AIDS / infectious diseases / infection / chronic hepatitis C / /
World Health Organization / Judy Gold Centre for Population Health / National Science Foundation / Infectious Diseases Society of America / Centers for Disease Control and Prevention / Centre for Population Health / Burnet Institute / NS NS / /
Person
Van Thiel / Neri / Rachel Sacks-Davis / /
Position
physician / /
Product
Cohorts Included Only Injection / Which Only Injection / Australia Injection / Hepatitis C Treatment / peginterferon / ribavirin / user / cohorts / /
PublishedMedium
The Australian annual / Clinical Infectious Diseases / /
Technology
treatment protocol / pdf / treatment Population treatment treatment protocol / treatment protocols / genotype / /
REVIEW ARTICLE Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence Margaret Hellard, Rachel Sacks-Davis, and Judy Gold Centre for Population Health, Burnet Institute, Melbourne, Australia